September 5, 2007 – According to Boston Scientific Corp., results from the TAXUS WOMAN study, a gender specific analysis ...
Guerbet’s flagship X-ray contrast agent, Oxilan (ioxilan) injection, is a contrast agent that is a nonionic, low-viscous ...
September 6, 2007 – Boston Scientific Corp. announced at the ESC 2007 conference in Vienna, Austria, that results from ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Siemens Medical Solutions Ultrasound Division’s syngo Arterial Health Package (AHP) application for cardiovascular risk ...
September 6, 2007 – The New England Journal of Medicine published the first study to demonstrate a clear superiority of ...
GE Healthcare Medical Diagnostics’ VISIPAQUE is reportedly the only isosmolar contrast medium (IOCM) available in the U.S. With an osmolality equal to that of blood, VISIPAQUE was designed for patient safety and comfort and is also formulated with sodium and calcium in a ratio equivalent to blood.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
St. Jude Medical Inc. announced that the FDA cleared the ACross Transseptal Access System, a device designed to improve control and simplify the procedure physicians use to access the left atrium during complex cardiac procedures such as atrial fibrillation ablation.
September 6, 2007 - Cleveland Clinic will host its fifth annual Medical Innovation Summit, an international gathering of healthcare, business and media leaders to examine trends in medical innovation and cardiovascular technologies, Oct. 1-3.
GE Healthcare has released the latest version of Centricity Enterprise, an intelligent and integrated software suite of clinical and financial applications that is designed to improve patient care and increase collaboration between clinicians, providing a better overall healthcare environment.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
September 5, 2007 - Clinical investigators at the European Society of Cardiology Congress 2007 (ESC Congress 2007) ...
September 5, 2007 - The National Institutes of Health has awarded its $5 million Bioengineering Research Partnership ...
September 5, 2007 - Edwards Lifesciences Corp. announced that it has received CE Mark approval for European commercial ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
September 5, 2007 - Results from a study on acute cardiogenic pulmonary edema, or "fluid on the lung," presented at the ...
September 4, 2007 - The first few minutes are instrumental in emergency situations and a new portable ultrasound device ...
September 4, 2007 - Agfa HealthCare demonstrated at the European Society of Cardiology Congress 2007 its new IMPAX ...
September 05, 2007
